Solitary extramedullary plasmacytoma of prostate on the background of treated prostate adenocarcinoma


Solitary extramedullary plasmacytoma of prostate on the background of treated prostate adenocarcinoma


Rehman Faryal, Amjad Hayat

University Hospital Galway, Galway, Ireland.


International-Journal-of-Case-Reports-2d code

Solitary Plasmacytoma is a rare entity which accounts for < 5% of all plasma cell dyscrasias. Most commonly involved sites for solitary extramedullary plasmacytoma are head and neck (90 %) especially upper respiratory tract, followed by Gastrointestinal tract. Rarely it can involve testes, bladder and orbit. PET/CT provides an invaluable imaging support for initial evaluation of additional plasmacytomas and response to treatment. There are no randomized trials regarding the best treatment approach. Generally, radiotherapy remains treatment of choice of solitary plasmacytoma. Our case, with its rare site of occurrence along with patient’s history of radiotherapy treated prostate malignancy and significant history of radiation cystitis provides a unique diagnostic and therapeutic challenge. Treatment can be personalised in cases such as this, where patients can be treated with chemotherapy in contrary to radiotherapy as further exposure to the radiations could exacerbate the bleeding risks.


Keywords: extramedullary plasmacytoma of prostate , prostate plasmacytoma


Free Full-text PDF


How to cite this article:

Rehman Faryal, Amjad Hayat. Solitary extramedullary plasmacytoma of prostate on the background of treated prostate adenocarcinoma. International Journal of Case Reports, 2020 4:132. DOI: 10.28933/ijcr-2020-05-1105


References:

1. Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol. 2009;144(1):86-94.
2. Lasocki, Arian & Furphy, Emma-Jane & Westerman, David & Harrison, Simon. (2020). Retinal ischemia due to extramedullary plasmacytomas of the orbit. Journal of Clinical Neuroscience. 10.1016/j.jocn.2020.01.052.
3. Shimokihara K, Kawahara T, Chiba S, Takamoto D, Yao M, Uemura H. Extramedullary plasmacytoma of the testis: A case report. Urol Case Rep. 2017;16:101-103.
4. Shimokihara K, Kawahara T, Chiba S, Takamoto D, Yao M, Uemura H. Extramedullary plasmacytoma of the testis: A case report. Urol Case Rep. 2017;16:101-103
5. Cormio L, Mancini V, Calò B, et al. Asymptomatic solitary bladder plasmocytoma: A case report and literature review. Medicine (Baltimore). 2017;96(50):e9347.
6. La Verde, Nicla & Moretti, Anna & Bramati, Annalisa & Bianchi, Filippo & Gherardi, Giorgio & Piva, Sheila & Girelli, Serena & Pedretti, Donata & Farina, Gabriella. (2012). Multiple Myeloma With Prostate Involvement: A Case Report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30. 10.1200/JCO.2012.42.7179.
7. Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, Samson D Guidelines Working Group of the UK Myeloma Forum.; British Committee for Standards in Haematology.; British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124:717-26.
8. Hu K1, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park) 2000;14:101-8.
9. Goyal, G., Bartley, A.C., Funni, S. et al. Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset. Leukemia 32, 1414-1420.
10. Schirrmeister, H., Buck, A.K., Bergmann, L., Reske, S.N. & Bommer, M. (2003) Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biotherapy & Radiopharmaceuticals, 18, 841–845.
11. Nanni, C., Rubello, D., Zamagni, E., Castellucci, P., Ambrosini, V., Montini, G., Cavo, M., Lodi, F., Pettinato, C., Grassetto, G., Franchi, R., Gross, M.D. & Fanti, S. (2008) 18F‐FDG‐PET/Ct in myeloma with presumed solitary plasmacytoma of bone. In Vivo, 22, 513–517.